Many people picture inflammatory bowel disease (IBD) as a condition confined to the digestive system, but the reality is more complex. Both Crohn’s disease and ulcerative colitis can trigger symptoms far beyond the gut, affecting joints, skin, eyes, and other organs. These extraintestinal manifestations can sometimes appear before digestive symptoms or persist even when the gut is in remission.
What Are Extraintestinal Manifestations?
Extraintestinal manifestations (EIMs) are symptoms or complications of IBD that occur outside the gastrointestinal tract. They affect approximately one in three people with IBD, though estimates vary. These manifestations arise from the same underlying immune dysregulation that drives gut inflammation, not from medication side effects or coincidental conditions.
Some EIMs track closely with bowel disease activity, flaring when gut inflammation worsens and improving when it settles. Others follow an independent course, appearing or persisting regardless of digestive system activity. Understanding this distinction shapes how each manifestation is monitored and managed.
Why IBD Affects More Than the Gut
In IBD, immune cells become overactive and misdirect their inflammatory response towards the gut lining. However, inflammatory signals produced in this process, including cytokines such as tumour necrosis factor alpha (TNF-alpha) and interleukin-17, circulate throughout the bloodstream and can trigger inflammation in distant tissues.
Some EIMs involve molecular mimicry, where the immune system mistakenly attacks tissues sharing structural similarities with gut bacteria. This helps explain why joint inflammation is so common in IBD. Genetic factors, including variations in genes such as HLA-B27, also increase the risk of specific EIMs, particularly those affecting the spine and joints.
Joint and Musculoskeletal Symptoms
Peripheral Arthritis
Peripheral arthritis affects large joints, particularly the knees, ankles, wrists, and elbows. It tends to flare alongside gut inflammation and often improves when bowel disease is controlled. The inflammation typically moves between joints and rarely causes permanent damage. Patients may notice swelling, warmth, and stiffness, particularly in the morning or after rest.
Axial Arthropathy
Axial arthropathy involves inflammation of the spine and sacroiliac joints, the connections between spine and pelvis. Unlike peripheral arthritis, axial symptoms do not always correlate with gut disease activity. Pain is often worse at night or early morning and improves with movement. Chronic inflammation can lead to stiffness and reduced spinal flexibility. The condition is more common in people carrying the HLA-B27 gene.
Enthesitis
Enthesitis refers to inflammation where tendons and ligaments attach to bone, commonly affecting the Achilles tendon and plantar fascia. It causes localised pain and tenderness that worsens with activity and may appear independently of gut symptoms.
Skin Manifestations
Erythema Nodosum
Erythema nodosum appears as tender, raised, red nodules, most often on the shins. These lesions usually flare in tandem with active gut disease and resolve without scarring once inflammation is controlled, though they can be painful whilst present.
Pyoderma Gangrenosum
Pyoderma gangrenosum is rarer but more serious. It begins as small pustules or red bumps that rapidly progress into deep, painful ulcers with irregular, undermined edges, most commonly on the legs. Unlike erythema nodosum, it does not always improve with control of gut inflammation and may require specific dermatological treatment. Minor trauma can trigger the condition, a phenomenon known as pathergy.
Eye Involvement
Episcleritis
Episcleritis is inflammation of the episclera, the thin tissue layer covering the white of the eye. It causes redness, mild discomfort, and a gritty sensation but does not typically affect vision. The condition often mirrors gut disease activity.
Uveitis
Uveitis is inflammation of the uvea, the middle eye layer, and represents a more serious complication. Symptoms include pain, blurred vision, light sensitivity, and floaters. Uveitis can develop independently of gut symptoms and, if untreated, may lead to permanent vision loss. Prompt ophthalmological assessment is essential.
Hepatobiliary Complications
The liver and bile ducts can also be affected. Primary sclerosing cholangitis (PSC) is a chronic condition characterised by inflammation and scarring of the bile ducts, leading to impaired bile flow. It occurs in approximately 5% of people with ulcerative colitis and, to a lesser extent, in Crohn’s disease. PSC often progresses silently, with elevated liver enzymes detected on routine blood tests before symptoms such as itching or jaundice appear. The condition increases the risk of bile duct and colorectal cancer, necessitating regular monitoring.
When Symptoms Do Not Match Inflammation
Not all symptoms are driven by active inflammation. Fatigue is extremely common in IBD but can persist during remission. Contributing factors include anaemia, sleep disturbance, medication side effects, and the psychological burden of chronic illness. Similarly, joint pain may result from deconditioning or mechanical strain rather than active arthritis.
This distinction matters because treatments targeting inflammation will not necessarily resolve symptoms with other causes. Thorough assessment, often involving blood tests, imaging, and specialist review, helps clarify what drives each symptom and guides appropriate management.
Practical Takeaways
- Monitor and report symptoms beyond the gut to your gastroenterology team, particularly new joint pain, skin changes, or eye discomfort.
- Do not dismiss symptoms appearing during remission; some extraintestinal manifestations follow an independent course.
- Keep a symptom diary to identify patterns and potential triggers.
- Attend regular monitoring appointments, including blood tests and specialist reviews, even when feeling well.
- Seek urgent medical attention for sudden vision changes, severe skin ulceration, or persistent high fever.
Conclusion
Inflammatory bowel disease extends beyond the digestive system, affecting joints, skin, eyes, and other organs in a significant proportion of patients. These extraintestinal manifestations arise from the same immune dysregulation that drives gut inflammation and require recognition and management as part of comprehensive IBD care. Understanding the link between systemic inflammation and distant symptoms helps patients and clinicians work together to minimise long-term complications and maintain quality of life.
References
- Vavricka SR, Schoepfer A, Scharl M, et al. Extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(8):1982-1992. doi:10.1097/MIB.0000000000000392
- Greuter T, Vavricka SR. Extraintestinal manifestations in inflammatory bowel disease: epidemiology, genetics, and pathogenesis. Expert Rev Gastroenterol Hepatol. 2019;13(4):307-317. doi:10.1080/17474124.2019.1574569
- Rogler G, Singh A, Kavanaugh A, Rubin DT. Extraintestinal manifestations of inflammatory bowel disease: current concepts, treatment, and implications for disease management. Gastroenterology. 2021;161(4):1118-1132. doi:10.1053/j.gastro.2021.07.042
- Harbord M, Annese V, Vavricka SR, et al. The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease. J Crohns Colitis. 2016;10(3):239-254. doi:10.1093/ecco-jcc/jjv213
- Arvikar SL, Fisher MC. Inflammatory bowel disease associated arthropathy. Curr Rev Musculoskelet Med. 2011;4(3):123-131. doi:10.1007/s12178-011-9085-8
- Hirschfield GM, Karlsen TH, Lindor KD, Adams DH. Primary sclerosing cholangitis. Lancet. 2013;382(9904):1587-1599. doi:10.1016/S0140-6736(13)60096-3
This article is intended for informational and educational purposes only. It does not constitute medical advice and should not be used as a substitute for professional medical guidance, diagnosis, or treatment.